Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study

  1. Iannaccone, M.
  2. D´Ascenzo, F.
  3. De Filippo, O.
  4. Gagliardi, M.
  5. Southern, D.A.
  6. Raposeiras-Roubín, S.
  7. Abu-Assi, E.
  8. Henriques, J.P.S.
  9. Saucedo, J.
  10. González-Juanatey, J.R.
  11. Wilton, S.B.
  12. Kikkert, W.J.
  13. Nuñez-Gil, I.
  14. Ariza-Sole, A.
  15. Song, X.
  16. Alexopoulos, D.
  17. Liebetrau, C.
  18. Kawaji, T.
  19. Huczek, Z.
  20. Nie, S.-P.
  21. Fujii, T.
  22. Correia, L.
  23. Kawashiri, M.-A.
  24. García-Acuña, J.M.
  25. Alfonso, E.
  26. Terol, B.
  27. Garay, A.
  28. Zhang, D.
  29. Chen, Y.
  30. Xanthopoulou, I.
  31. Osman, N.
  32. Möllmann, H.
  33. Shiomi, H.
  34. Kowara, M.
  35. Filipiak, K.
  36. Wang, X.
  37. Yan, Y.
  38. Fan, J.-Y.
  39. Ikari, Y.
  40. Nakahashi, T.
  41. Sakata, K.
  42. Yamagishi, M.
  43. Moretti, C.
  44. Gaita, F.
  45. Kalpak, O.
  46. Kedev, S.
  47. Show all authors +
Journal:
American Journal of Cardiovascular Drugs

ISSN: 1179-187X 1175-3277

Year of publication: 2017

Volume: 17

Issue: 1

Pages: 61-71

Type: Article

DOI: 10.1007/S40256-016-0196-X GOOGLE SCHOLAR

Sustainable development goals